Neurofeedback training shows no benefit for attention and inhibition in adults with ADHD
Neurofeedback fails to improve attention in adults with ADHD
This randomized controlled trial in 44 adults with ADHD compared neurofeedback training to a waitlist control.
A widely used brain-training therapy for adult ADHD shows no meaningful gains in attention or self-control, despite years of hope and market…
Analysis of 247,657 reports identifies central nervous system medications with suicide-related adverse event signals
Researchers find central nervous system drugs associated with suicide reports
This cohort study analyzed 247,657 reports from the U.S.
Central nervous system medications showed the strongest link to suicide events in over two hundred thousand FDA reports.
Computational model shows individualized gamma stimulation outperforms fixed frequency in Alzheimer's simulation
Computational model suggests personalized stimulation beats fixed frequency for Alzheimer's
This computational model study simulated 200 individuals with Alzheimer's disease to compare individualized gamma frequency stimulation vers…
A simulated study indicates individualized frequency stimulation offers a four-fold advantage over fixed 40 Hz stimulation for Alzheimer's d…
Review of cross-sectional EEG study on 32-Hz stimulation in Alzheimer's disease and mild cognitive impairment
Why Some Brains Respond Better to Gamma Stimulation in Alzheimer's
This review summarizes a cross-sectional EEG study evaluating 32-Hz visual stimulation in adults aged 55 years or older with Alzheimer's dis…
People with lower cognitive reserve showed bigger brain network changes during gamma stimulation, suggesting who might benefit most.
Qualitative review highlights barriers to recognizing autism in women with borderline personality disorder diagnoses
Many women with BPD may actually be autistic
This qualitative review synthesizes interviews with 15 clinicians and 15 women or people assigned female at birth regarding autism recogniti…
Hundreds of women told doctors they were misdiagnosed with borderline personality disorder when they may actually be autistic, raising urgen…
FDA Approves Caplyta (lumateperone) for Schizophrenia in Adults
FDA approves Caplyta to treat schizophrenia in adults
FDA approved Caplyta (lumateperone) for treatment of schizophrenia in adults.
The FDA approved Caplyta (lumateperone) for treating schizophrenia in adults.
FDA Approves Mydayis (mixed salts of a single-entity amphetamine) for ADHD in Patients 13 and Older
FDA approves new ADHD drug Mydayis for patients 13 and older
FDA approved Mydayis, a CNS stimulant, for ADHD in patients 13 years and older.
The FDA approved Mydayis, a once-daily stimulant for ADHD in people 13 and older. It can last up to 16 hours, which may cause insomnia. This…
FDA Approves Vyvanse (lisdexamfetamine) for Binge Eating Disorder in Adults
FDA approves Vyvanse to treat binge eating disorder in adults
The FDA approved Vyvanse (lisdexamfetamine) for moderate to severe binge eating disorder (BED) in adults.
The FDA has approved Vyvanse (lisdexamfetamine) for moderate to severe binge eating disorder in adults.
FDA Approves Vyvanse (lisdexamfetamine) for Binge Eating Disorder
FDA approves Vyvanse to treat binge eating disorder in adults
FDA approved Vyvanse (lisdexamfetamine) for moderate to severe binge eating disorder (BED) in adults.
The FDA approved Vyvanse for moderate to severe binge eating disorder in adults. It is a stimulant already used for ADHD. This gives patient…
Perinatal depression prevalence in Ethiopian women ranges from 20.1% to 25.8% based on pooled meta-analysis data
One in four Ethiopian mothers faces depression before and after birth
This umbrella review and meta-analysis examined perinatal depression among women in Ethiopia, pooling data from 15,592 participants.
Nearly one in four mothers in Ethiopia experiences depression, a serious issue that demands immediate attention and better care.
Executive function training reduces anxiety and depression in working adults, CBT app improves workplace well-being
Brain Training App Eases Anxiety and Depression at Work
This randomized controlled trial in 228 working adults with mild-to-moderate depression and anxiety compared app-based executive function tr…
A simple brain training app eased anxiety and depression in workers, while a popular CBT app boosted workplace well-being but didn’t reduce …
Narrative review explores microbiome mechanisms as a promising adjunctive avenue for managing depression, anxiety, bipolar disorder, and schizophrenia
Gut Bacteria Can Change Your Mood
This narrative review examines how microbiome-driven modulation of neurotransmitters, microbial metabolites, immune activation, and vagal ne…
What if the bacteria in your gut could be quietly shaping how you feel every day — and fixing them could ease anxiety or depression?